News

DX-2930 is currently being developed by the company as a subcutaneous injection for prevention of HAE attacks. The company noted that uncontrolled pKal activity leads to excessive generation

As part of this deal, the university is looking forward to advancing new formulations of CBD to meet serious medical conditions where non-psychotropic cannabinoids can play a significant

Around 60 healthy volunteers will be enrolled in the randomized, double-blinded, placebo-controlled Phase I trial, which is currently underway in Belgium. The company said that potential indications for

Under the deal, Incyte will provide financial support for Vanderbilt’s grant-based research program, which has an initial collaboration period of three years, with the option to extend. The

Founded by Eric Casaburi, CEO and founder of Retro Fitness, Fierce Nutritionals was designed to offer active adults and athletes multiple sports nutrition solutions. After recognizing a need

Sernova and Dr. Mark Poznansky, M.D., Ph.D., Associate Professor of Medicine at Harvard Medical School and Director of the Vaccine and Immunotherapy Center at Massachusetts General Hospital will

The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin

The deal is subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR). Allergan will buy these rights for an

The transaction will enhance Hi-Tech’s leading Sports Nutrition and Weight Loss arsenal and expand its position as the leader in Diet & Energy products in the United States.